Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim
McKinsey
Harvard Business School
Merck

Last Updated: May 20, 2022

CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Clindamycin Phosphate And Benzoyl Peroxide, and what generic alternatives are available?

Clindamycin Phosphate And Benzoyl Peroxide is a drug marketed by Actavis Labs Ut Inc, Anda Repository, Encube, Glenmark Pharms, Mylan Pharms Inc, Padagis Israel, Taro, Taro Pharms, Tolmar, and Zydus Pharms. and is included in fifteen NDAs.

The generic ingredient in CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE is benzoyl peroxide; clindamycin phosphate. There are seventeen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the benzoyl peroxide; clindamycin phosphate profile page.

Summary for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Drug patent expirations by year for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Recent Clinical Trials for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Bausch Health Americas, Inc.Phase 2
Icahn School of Medicine at Mount SinaiPhase 2
Valeant Pharmaceuticals International, Inc.Phase 2

See all CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE clinical trials

Pharmacology for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

US Patents and Regulatory Information for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 205128-001 Jun 19, 2015 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Padagis Israel CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 205397-001 Sep 9, 2019 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Encube CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 212433-001 Apr 28, 2021 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Taro CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 208776-001 May 25, 2018 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Dow
Moodys
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.